Back to Search
Start Over
Ziopharm Oncology Completes Enrollment of Phase 2 Trial Evaluating Controlled IL-12 in Combination with Libtayo(R) in Patients with Glioblastoma
- Source :
- GlobeNewswire. June 22, 2020
- Publication Year :
- 2020
-
Abstract
- BOSTON, June 22, Jun 22, 2020 (GLOBE NEWSWIRE via COMTEX) -- Ziopharm Oncology, Inc. ('Ziopharm' or 'the Company') (Nasdaq:ZIOP) today announced that 36 subjects have been enrolled in the phase [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.627281383